Rong G Liu

US Patent:

7592315, Sep 22, 2009

Filed:

Nov 1, 2005

Appl. No.:

11/264509

Inventors:

Rong Liu - Scotch Plains NJ, US
Rumin Zhang - Edison NJ, US
Rong Kong - Scotch Plains NJ, US

Assignee:

Schering Corporation - Kenilworth NJ

International Classification:

A01N 37/18
A61K 38/16
A61K 38/21
A61K 39/42
G01N 33/00

US Classification:

514 13, 514 8, 514 11, 514 5, 514 6, 514 9, 514 7, 436 87, 530317, 530326, 435 691

Abstract:

The present invention provides, inter alia, peptide compositions and methods for treating and preventing Flaviviridae virus (e. g. , hepatitis C virus) infections.

US Patent:

20070298096, Dec 27, 2007

Filed:

Oct 26, 2005

Appl. No.:

11/666528

Inventors:

Rong Liu - Warren NJ, US
Michael Corbo - Flemington NJ, US
Jatin Desai - Plainsboro NJ, US
Gerard Frunzi - Douglaston NY, US
Xiaohong Qi - Irvington NJ, US
Candice Choi - Palisades Park NJ, US
Rahul Gandhi - Plainsboro NJ, US
Atef Boulos - Rockaway NJ, US

International Classification:

A61K 9/48
A61K 31/52
A61P 25/04

US Classification:

424451000, 514263100

Abstract:

The onset of activity of a first analgesic/antipyretic composition containing an analgesic/antipyretic effective amount of acetaminophen, caffeine and, optionally, aspirin is shortened by incorporating in the first composition an onset of analgesic/antipyretic activity shortening amount of at least one alkaline agent whereby a second composition is produced. The second composition being bioequivalent to the first composition but having a shorter onset of analgesic/antipyretic activity than the first composition.

US Patent:

20100119483, May 13, 2010

Filed:

Jul 23, 2009

Appl. No.:

12/508095

Inventors:

Rong Liu - Scotch Plains NJ, US
Rumin Zhang - Edison NJ, US
Rong Kong - Scotch Plains NJ, US

International Classification:

A61K 38/21
C07K 2/00
A61K 38/02
A61K 39/395
C07H 21/00
C12N 15/74
C12N 5/071
C12P 21/02
A61P 31/12
A61P 31/14
A61P 31/18
A61P 37/04

US Classification:

424 857, 530300, 514 2, 4241301, 424 854, 536 231, 4353201, 435325, 435 691

Abstract:

The present invention provides, inter alia, peptide compositions and methods for treating and preventing Flaviviridae virus (e.g., HCV) infections.

US Patent:

20120297390, Nov 22, 2012

Filed:

May 17, 2011

Appl. No.:

13/109560

Inventors:

Richard B. Hull - Chatham NJ, US
Rong Liu - Sterling VA, US
Anil Nigam - Stamford CT, US
Florian Pinel - New York NY, US
Frederick Y. Wu - Greenwich CT, US

Assignee:

INTERNATIONAL BUSINESS MACHINES CORPORATION - Armonk NY

International Classification:

G06F 9/46

US Classification:

718102

Abstract:

Execution of flexible workflows using artifacts is described. A workflow execution engine is configured to instantiate a process execution (PE) artifact. The PE artifact includes one or more transitions. The workflow execution engine is further configured to execute the one or more transitions and determine if any of the one or more transitions are new or modified. The workflow execution engine is additionally configured to load and execute new or modified transitions, without reinstantiating the PE artifact, responsive to determining that at least one new or modified transitions exist.